在狗老化项目中,伴侣犬的第一个并发症网络
Antoinette Fang1, Lakshin Kumar2, Kate E Creevy3
1Department of Mathematics, University of Chicago.
bioRxiv : the preprint server for biology
|January 7, 2025
概括
伴侣狗,共享人类疾病,提供了关于衰老和并发性疾病的见解. 分析狗的健康数据揭示了疾病网络,老犬的复杂性增加,有利于兽医和人类医学.
科学领域:
- 地质科学是地球科学.
- 兽医流行病学 兽医流行病学
- 网络分析 网络分析
背景情况:
- 伴随性疾病及其与衰老的关系是老年科学中的关键领域.
- 伴侣犬与人类有着许多共同的疾病,这使得它们成为有价值的模范.
- 了解犬类并发症可以促进兽医和人类的健康.
研究的目的:
- 分析使用狗老化项目的数据的狗共患病网络.
- 为了确定伴侣狗健康状况之间的关联.
- 探索年龄如何影响狗的并发症模式.
主要方法:
- 在一大批伴侣狗 (n=26,523) 中分析了所有者报告的健康状况.
- 使用Poisson二项式测试构建非定向和定向并发症网络.
- 对包括年龄,性别,绝育状态,品种和体重在内的共变量进行调整.
主要成果:
- 确定已知的并发症 (例如,糖尿病与失明,高血压与慢性病).
- 揭示了较少研究的关联 (例如,蛋白尿与贫血).
- 年龄分层分析显示,随着年龄的增长,网络的中心性增加,在老犬中达到顶峰.
结论:
- 伴随性疾病网络分析是了解狗健康的强大工具.
- 这些发现增强了临床知识,并可以为犬类保健管理提供信息.
- 这种方法为伴侣动物的衰老和疾病提供了有价值的见解.
相关概念视频
Aging
36
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
36
Alzheimer's Disease: Overview
444
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
444
Alzheimer's Disease: Treatment
161
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
161
Chronic Pancreatitis II: Collaborative Care
70
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
70
Parkinson's Disease: Overview
472
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
472
The Effect of Aging on Tissues
2.1K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
2.1K


